Axinn has carved out a niche
by specializing
in the overlap of
intellectual property and antitrust, in addition to its record of complex and high-profile cases.
Its offices are
based
in the northeast – New York, District of Columbia, and Hartford,
Connecticut –
apart from its California residence in San Francisco.
Clients routinely point out the firm’s diversity in its teams as well as its
casework.
While the firm has expanded beyond its Connecticut beginnings, the Hartford headquarters continues to be a dominant force in litigation. The Hartford office
has three of the firm’s top intellectual property litigators.
Matt Becker
and
Ted Mathias
lead the team defending
Alvogen in a patent infringement lawsuit filed in the District of New Jersey
by Indivior in relation to the client’s generic Suboxone film product. This case follows a District of Delaware case in which the team prevailed.
Beck and Mathias were joined by
Chad Landmon
to defend
Norwich, an
Alvogen
company, against a patent infringement case filed by Takeda. The lawsuit involves 18 patents and more than 400 patent claims. Landmon and Becker lead the case at the federal circuit with Mathias. Landmon recently secured a favorable ruling in a four-day trial
representing
Norwich Pharmaceuticals.
The District of Delaware issued a full opinion asserting that the claims related to the composition of matter and methods of using rifaximin
are
invalid as obvious. Both Landmon and Becker specialize in serving the life sciences industry.
Becker’s
expertise
is in Hatch-Waxman lawsuits and Landmon’s secondary
expertise
is handling matters related to the Food and Drug Administration.
Mathias’ biotechnology focus involves industries beyond the life sciences to include technology and software companies and related issues.
The firm’s office in the District of Columbia features antitrust specialist
Rachel Adcox,
who joined her colleagues as a Litigation Star this year.
Adcox has also represented
Alvogen, but in an antitrust context.
She has led the team in defending the company in the Generic Drugs MDL litigated in the Eastern District of Pennsylvania. The case was
filed by 44
attorneys
general. A Department of Justice criminal antitrust investigation arose out of the matter as well. Adcox defends the client against allegations that
pharmaceuticals companies raised prices of generic medications. The case has garnered significant media and public attention and continues to be litigated nationwide. Adcox and New York antitrust litigator Denise Plunkett
were lead counsels in a case defending Alliance for Safe Online Pharmacies in a lawsuit alleging a conspiracy to prevent the plaintiff, Pharmacychecker.com, from accessing platforms to promote the importation of pharmaceuticals outside the US. Adcox and Plunkett secured early and exclusive discovery
that provided the basis for summary judgment.
Plunkett’s trial flair was also featured in a high-profile case
representing World Chess Champion and Grandmaster Magnus Carlsen in a defamation and antitrust lawsuit alleging Section 1 and 2 violations filed by Grandmaster Hans Neimann in the Eastern District of Missouri. Plunkett moved to dismiss the plaintiff’s
initial lawsuit, but the court allowed for an amended complaint. She has again renewed the motion to dismiss which has been fully briefed. Aziz Burgy
is one of the top life sciences litigators in the DC office. He represents Endo Ventures and Par Pharmaceuticals against
competitor Nexus in a patent infringement lawsuit involving
ready-to-use ephedrine prefilled syringe products yet to hit the market. Several lawsuits have been filed over the patents for the newly approved products. Endo and Par’s case against Nexus settled; however, Burgy is also
representing
Nevakar in a closely
watched case against Baxter related to the same ready-to-use
product.
